Sciencast Management LP purchased a new stake in Quintiles Transitional Holdings Inc. (NYSE:Q) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 2,300 shares of the medical research company’s stock, valued at approximately $206,000.
Other hedge funds have also recently made changes to their positions in the company. Fiduciary Trust Co. acquired a new stake in Quintiles Transitional Holdings in the second quarter valued at $105,000. Global X Management Co. LLC lifted its stake in Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after acquiring an additional 346 shares during the last quarter. Korea Investment CORP lifted its stake in Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after acquiring an additional 805 shares during the last quarter. Archford Capital Strategies LLC acquired a new stake in Quintiles Transitional Holdings in the first quarter valued at $160,000. Finally, Citigroup Inc. lifted its stake in Quintiles Transitional Holdings by 15.5% in the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock valued at $167,000 after acquiring an additional 250 shares during the last quarter. Hedge funds and other institutional investors own 93.21% of the company’s stock.
A number of research firms have recently issued reports on Q. BidaskClub upgraded shares of Quintiles Transitional Holdings from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 19th. Zacks Investment Research cut shares of Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a research note on Thursday. Citigroup Inc. restated a “neutral” rating and set a $96.00 target price (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research note on Wednesday, June 28th. Robert W. Baird upgraded shares of Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $76.00 to $93.00 in a research note on Friday, July 7th. Finally, Royal Bank Of Canada began coverage on shares of Quintiles Transitional Holdings in a research note on Tuesday, September 19th. They set an “outperform” rating and a $116.00 target price for the company. Eleven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Quintiles Transitional Holdings has an average rating of “Buy” and an average target price of $93.61.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/10/12/sciencast-management-lp-purchases-new-position-in-quintiles-transitional-holdings-inc-q.html.
In other news, major shareholder Cpp Investment Board Private H sold 6,748,026 shares of the stock in a transaction dated Tuesday, September 19th. The shares were sold at an average price of $94.87, for a total value of $640,185,226.62. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Kevin C. Knightly sold 20,000 shares of the stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the sale, the insider now directly owns 46,826 shares in the company, valued at $4,227,451.28. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 14,198,382 shares of company stock worth $1,361,834,375. Insiders own 6.40% of the company’s stock.
Shares of Quintiles Transitional Holdings Inc. (NYSE Q) traded up 0.50% during mid-day trading on Thursday, reaching $98.25. 65,772 shares of the company’s stock traded hands. The firm has a 50-day moving average of $95.69 and a 200 day moving average of $88.65. The company has a market cap of $21.27 billion, a P/E ratio of 284.78 and a beta of 0.62. Quintiles Transitional Holdings Inc. has a 12-month low of $70.10 and a 12-month high of $99.95.
Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The business had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The company’s revenue was up 68.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.93 earnings per share. Equities analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.
Quintiles Transitional Holdings Company Profile
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.